Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer

Gynecologic Oncology

Volumn 138, Issue 1, 2015, Pages 121-127

  Hodeib, Melissa ^a   Chang, Jenny ^a   Liu, Fong ^a   Ziogas, Argyrios ^a   Dilley, Sarah ^b   Randall, Leslie M ^a   Anton Culver, Hoda ^a   Bristow, Robert E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adherent care; NCCN; Ovary cancer; Socioeconomic status

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BLACK PERSON; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CAUCASIAN; CYTOREDUCTIVE SURGERY; EARLY CANCER; FEMALE; FOLLOW UP; HIGH VOLUME HOSPITAL; HISPANIC; HUMAN; LOW VOLUME HOSPITAL; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MANAGED CARE; MEDICALLY UNINSURED; MEDICARE; MIDDLE AGED; OMENTECTOMY; OVARIECTOMY; OVARY CARCINOMA; PACIFIC ISLANDER; PATIENT COMPLIANCE; PHYSICIAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SOCIAL STATUS; CANCER STAGING; ECONOMICS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; REGISTER; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; FEMALE; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; SOCIAL CLASS; YOUNG ADULT;

EID: 84931577813     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.04.011     Document Type: Article

References (19)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 1 2014 9 29
2. R.E. Bristow, J. Chang, A. Ziogas, and H. Anton-Culver Adherence to treatment guidelines for ovarian cancer as a measure of quality care Obstet. Gynecol. 121 6 2013 1226 1234
3. J.K. Chan, M. Zhang, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States J. Surg. Oncol. 97 2 2008 103 107
4. R.E. Bristow, M.A. Powell, N. Al-Hammadi, L. Chen, J.P. Miller, and P.Y. Roland Disparities in ovarian cancer care quality and survival according to race and socioeconomic status J. Natl. Cancer Inst. 105 11 2013 823 832
5. E.A. Howell, N. Egorova, M.P. Hayes, J. Wisnivesky, R. Franco, and N. Bickell Racial disparities in the treatment of advanced epithelial ovarian cancer Obstet. Gynecol. 122 5 2013 1025 1032
6. A. Parikh-Patel, M. Allen, W.E. Wright, and California Teachers Study Steering C Validation of self-reported cancers in the California Teachers Study Am. J. Epidemiol. 157 6 2003 539 545
7. K. Yost, C. Perkins, R. Cohen, C. Morris, and W. Wright Socioeconomic status and breast cancer incidence in California for different race/ ethnic groups Cancer Causes Control 12 2001 703 711
8. B.A. Goff, B.J. Matthews, M. Wynn, H.G. Muntz, D.M. Lishner, and L.M. Baldwin Ovarian cancer: patterns of surgical care across the United States Gynecol. Oncol. 103 2 2006 383 390
9. B.A. Goff, B.J. Matthews, E.H. Larson, C.H. Andrilla, M. Wynn, and D.M. Lishner Predictors of comprehensive surgical treatment in patients with ovarian cancer Cancer 109 10 2007 2031 2042
10. R.E. Bristow, M.L. Zahurak, T.P. Diaz-Montes, R.L. Giuntoli, and D.K. Armstrong Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes Gynecol. Oncol. 115 3 2009 334 338
11. R.E. Bristow, B.E. Palis, D.S. Chi, and W.A. Cliby The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm Gynecol. Oncol. 118 3 2010 262 267
12. R.J. Morgan Jr. Ovarian cancer guidelines: treatment progress and controversies J. Natl. Compr. Cancer Netw. 9 1 2011 4 5
13. R.J. Morgan Jr., R.D. Alvarez, D.K. Armstrong, B. Boston, R.A. Burger, and L.M. Chen Epithelial ovarian cancer J. Natl. Compr. Cancer Netw. 9 1 2011 82 113
14. R.J. Morgan Jr., R.D. Alvarez, D.K. Armstrong, R.A. Burger, M. Castells, and L.M. Chen Ovarian cancer, version 3.2012 J. Natl. Compr. Cancer Netw. 10 11 2012 1339 1349
15. T.E. Byers, H.J. Wolf, K.R. Bauer, S. Bolicka Aldrich, V.W. Chen, and J.L. Finch The impact of socioeconomic status on survival after cancer in the United States Cancer 113 3 2008 582 591
16. L.C. Harlan, L.X. Clegg, and E.L. Trimble Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 21 18 2003 3488 3494
17. L.C. Harlan, A.L. Greene, L.X. Clegg, M. Mooney, J.L. Stevens, and M.L. Brown Insurance status and the use of guideline therapy in the treatment of selected cancers J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 23 36 2005 9079 9088
18. B.K. Erickson, J.Y. Martin, M.M. Shah, J.M. Straughn Jr., and C.A. Leath 3rd. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center Gynecol. Oncol. 133 2 2014 142 146
19. R.E. Bristow, J. Chang, A. Ziogas, H. Anton-Culver, and V.M. Vieira Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status Gynecol. Oncol. 134 1 2014 60 67